NOVOZYMES BIOINDUSTRIAL CHINA A/S: Financial statements 2019
CVR: 21599042
NOVOZYMES BIOINDUSTRIAL CHINA A/S (CVR 21599042) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -37,500 and a net result of DKK 283,492,654 compared with DKK -53,650 the year before. Equity amounted to DKK 1,052,111,768. The solvency ratio was 100%.
- Gross Profit
- -37,500 kr.
- Profit/Loss
- 283,492,654 kr.
- Equity
- 1,052,111,768 kr.
- Total Assets
- 1,052,111,768 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -38 t. | 283.5 mio. | 1.1 mia. | 0 |
| 2018 | - | -68 t. | -54 t. | 768.6 mio. | - |
| 2017 | - | -73 t. | -58 t. | 770.2 mio. | - |
| 2016 | - | -78 t. | -61 t. | 770.2 mio. | - |
| 2015 | - | -90 t. | -69 t. | 770.3 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
NOVOZYMES BIOINDUSTRIAL CHINA A/S has published its annual report for 2018. Gross profit came to DKK -67,702, and the net result was DKK -53,650.
About NOVOZYMES BIOINDUSTRIAL CHINA A/S
NOVOZYMES BIOINDUSTRIAL CHINA A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1999. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Lisbet Kragelund. The company is owned by NOVOZYMES A/S. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 119,380,365 compared with DKK 394,633,084 the year before. Equity amounted to DKK 1,018,536,331.
